| ADC | Apparent Diffusion Coefficient |
| ALF | Acute Liver Failure |
| AQP4 | Aquaporin 4 |
| ASPECTS | Alberta Stroke Program Early CT Score |
| ASTRAL | Antagonizing SUR1-TRPM4 To Reduce the progression of intracerebral Hematoma and edema surrounding Lesions |
| ATP | Adenosine Triphosphate |
| BAX | Bcl-Associated X protein |
| BBB | Blood–Brain Barrier |
| BSCB | Blood–Spinal Cord Barrier |
| BTB | Brain–Tumor Barrier |
| CAMKII | Calmodulin-Dependent Protein Kinase II |
| CCI | Controlled Cortical Impact |
| CHARM | Ciara in Large Hemispheric Infarction Analyzing Modified Rankin and Mortality |
| CNS | Central Nervous System |
| COX2 | Cyclooxygenase 2 |
| CSF | Cerebrospinal Fluid |
| DC | Decompressive Craniectomy |
| FLAIR | Fluid-Attenuated Inversion Recovery |
| FPI | Fluid Percussion Injury |
| FRET | Förster Resonance Energy Transfer |
| GAIN | Genetic Association in Neurotrauma |
| GAMES | Glyburide Advantage in Malignant Edema and Stroke |
| GASH | Glibenclamide in Aneurysmatic Subarachnoid Hemorrhage |
| GCS | Glasgow Coma Scale |
| GFAP | Glial Fibrillary Acidic Protein |
| GOS | Glasgow Outcome Scale |
| HAND | HIV Associated Neurocognitive Disorder |
| HIF1α | Hypoxia inducible factor 1α |
| ICH | Intracerebral Hemorrhage |
| IFNγ | Interferon-γ |
| IL-17 | Interleukin-17 |
| iNOS | inducible Nitric Oxide Synthase |
| LHI | Large Hemispheric Infarction |
| MA | Mithramycin-A |
| MCAO | Middle Cerebral Artery Occlusion |
| MMP-9 | Matrix Metalloproteinase-9 |
| MRI | Magnetic Resonance Imaging |
| NeuN | Neuronal Nuclear Protein |
| NF-κB | Nuclear Factor κ- Light-Chain Enhancer of Activated B cells |
| NO | Nitric Oxide |
| NOS2 | Nitric Oxide Synthase 2 |
| NBS | Nucleotide Binding Site |
| NIHSS | National Institute of Health Stroke Scale |
| OBTT | Operation Brain Trauma Therapy |
| PACAP | Pituitary Adenylate Cyclase-Activating Polypeptide |
| PHN | Progressive Hemorrhagic Necrosis |
| SAH | Subarachnoid Hemorrhage |
| SCI | Spinal Cord Injury |
| SCING | Spinal Cord Injury Neuroprotection with Glyburide |
| Sp1 | Specificity Protein 1 |
| SUR1 | Sulfonylurea Receptor 1 |
| TAA | Thioacetamide |
| TBI | Traumatic Brain Injury |
| TLR4 | Toll-like Receptor 4 |
| tPA | Tissue Plasminogen Activator |
| TNFα | Tumor Necrosis factor α |
| TRPM4 | Transient Receptor Potential Melastatin 4 |
| VISTA | Virtual International Stroke Trial Archive |
| vWF | Von Willebrand Factor |
| ZO-1 | Zona Occludens 1 |